BNP Paribas Financial Markets’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.29M Buy
390,745
+245,300
+169% +$2.93M ﹤0.01% 2061
2026
Q1
$871K Buy
145,445
+122,621
+537% +$923K ﹤0.01% 3238
2025
Q4
$164K Sell
22,824
-934,843
-98% -$7.39M ﹤0.01% 4149
2025
Q3
$10.2M Buy
957,667
+737,935
+336% +$7.24M 0.01% 1527
2025
Q2
$2.13M Sell
219,732
-211,646
-49% -$2.18M ﹤0.01% 2422
2025
Q1
$6.42M Buy
431,378
+267,665
+163% +$4.12M ﹤0.01% 1653
2024
Q4
$2.44M Buy
+163,713
New +$2.67M ﹤0.01% 2259
2024
Q1
Sell
-108
Closed -$1.56K 4174
2023
Q4
$1.56K Buy
+108
New +$1.47K ﹤0.01% 3818
2022
Q4
Sell
-104,017
Closed -$2.43M 4429
2022
Q3
$2.43M Buy
+104,017
New +$3.14M ﹤0.01% 1838

Other funds holding OGN

BNP Paribas Financial Markets's OGN Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Organon & Co (OGN) stake by 169% in Q2 2026, buying an estimated $2.93M and bringing the position to 390,745 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

BNP Paribas Financial Markets first reported a position in OGN in Q3 2022 and has held it in 9 quarters since. The position peaked at $10.2M in Q3 2025. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • BNP Paribas Financial Markets held 390,745 shares of Organon & Co worth $5.29M as of Q2 2026.
  • BNP Paribas Financial Markets bought 245,300 Organon & Co shares in Q2 2026, an estimated $2.93M.
  • Organon & Co made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2061 holding.
  • BNP Paribas Financial Markets first reported a position in Organon & Co in Q3 2022 and has held it in 9 quarters since.
  • BNP Paribas Financial Markets's Organon & Co position peaked at $10.2M in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.